ANCA associated vasculitis - ScienceDirect
MAINtenance of remission with RITuximab versus azathioprine for patients with newly-diagnosed or relapsing Eosinophilic Granulom
Frontiers | Clinical characteristics and long-term outcome of patients with gastrointestinal involvement in eosinophilic granulomatosis with polyangiitis
Comparison of severity classification in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a n
The Korean Journal of Internal Medicine
Occupational Exposures and Smoking in Eosinophilic Granulomatosis With Polyangiitis: A Case–Control Study - Maritati - 2021 - Arthritis & Rheumatology - Wiley Online Library
Frontiers | Clinical characteristics and long-term outcome of patients with gastrointestinal involvement in eosinophilic granulomatosis with polyangiitis
Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review
Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort - Comarmond - 2013 - Arthritis & Rheumatism - Wiley Online Library
Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) enrolled in two prospective trials - ScienceDirect
PDF) Update on eosinophilic granulomatosis with polyangiitis
PDF) Neutrophil to lymphocyte ratio at diagnosis can estimate vasculitis activity and poor prognosis in patients with ANCA-associated vasculitis: A retrospective study
Vaccines | Special Issue : Allergic Reactions to Current Available COVID-19 Vaccines
PDF) Red Blood Cell Distribution Width Can Predict Vasculitis Activity and Poor Prognosis in Granulomatosis with Polyangiitis
Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial | PLOS ONE
2 Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndro
The Pulmonary Vasculitides - ppt video online download
Treatment of Systemic Necrotizing Vasculitides in Patients Aged Sixty‐Five Years or Older: Results of a Multicenter, Open‐Label, Randomized Controlled Trial of Corticosteroid and Cyclophosphamide–Based Induction Therapy - Pagnoux - 2015 - Arthritis
Serum chitinase-3-like 1 protein is a useful biomarker to assess disease activity in ANCA-associated vasculitis: an observational study | Arthritis Research & Therapy | Full Text
Five factors score in patients with eosinophilic granulomatosis with polyangiitis (Churg–Strauss; EGPA): to use or not to use?
![PDF] Clinical features and prognostic factors of Churg-Strauss syndrome | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/51ebf4558271a5eedd8568631edf87751abe1e87/8-Table5-1.png "PDF] Clinical features and prognostic factors of Churg-Strauss syndrome | Semantic Scholar")
PDF] Clinical features and prognostic factors of Churg-Strauss syndrome | Semantic Scholar
